Introduction
It is now clear that most signal transduction pathways evolved early in the history of metazoan development and have been conserved from Drosophila to humans. Indeed, components of the Ras-MAP kinase pathway were elucidated by a combination of biochemical interactions in mammalian cell culture and Drosophila genetics (Rubin et al., 1997) . Although the genetics of Ras signalling initially described the role of this pathway in cell fate determination recent work has shown that activated Ras is capable of inducing hyperplasia of the developing retina, and this eect can be enhanced by mutations that exacerbate deregulation of Ras signalling (Karim and Rubin, 1998) .
Drosophila has realized an expanding role in cancer research with the identi®cation of homologues of human oncogenes and mutations that result in tumour growth or over-proliferation. Genetic modi®er screens have allowed the identi®cation of genes that interact with tumorigenic mutations, providing a method to uncover new regulators of signal transduction (Potter et al., 2000) .
D-Cbl is a member of an expanding family of adaptor proteins with a central role in down-regulation of a diverse range of signalling pathways . This negative regulation can in part be attributed to intrinsic E2-dependent ubiquitin-protein ligase activity contained within the RING ®nger domain of Cbl proteins (Joazeiro et al., 1999) . In accord with this, c-Cbl is transiently ubiquitinated upon activation of colony-stimulating factor-1 receptor (CSF-1R) (Wang et al., 1996) and enhances the ubiquitination of activated receptors (Lee et al., 1999; Levkowitz et al., 1998; Miyake et al., 1998) . There are four known oncogenic forms of Cbl (see Figure 1a ): vCbl has a C-terminal truncation leaving only an SH2 domain (Blake et al., 1991) ; 70Z-Cbl has a 17 aminoacid deletion encompassing the ®rst cysteine of the RING ®nger; and CblDY368 and CblDY371 have deletions of single tyrosines from within the 70Z deletion (Andoniou et al., 1994) . v-Cbl and 70Z-Cbl are both defective in ubiquitin ligase activity, while CblDY368 has wild-type activity (Joazeiro et al., 1999) ; CblDY371 has not been tested. Interestingly, CblY371F is defective for ubiquitin ligase activity (Levkowitz et al., 1999) but is not transforming (Andoniou et al., 1994) . This suggests that Cbl proteins may have additional functions, mediated by motifs outside the RING ®nger, that contribute to transformation.
c-Cbl contains a variant SH2 domain at the Nterminus that binds to receptor and intracellular tyrosine kinases (Bonita et al., 1997; Meng et al., 1999; Thien and Langdon, 1997b) , the RING ®nger, and a C-terminal UBA domain, common to many proteins involved in ubiquitination but of unknown function (Hofmann and Bucher, 1996) . Between the RING ®nger and the UBA domain there are a number of phosphotyrosines and proline rich motifs that mediate interactions with SH2 and SH3 domain proteins (Andoniou et al., 1994; Thien and Langdon, 1997a) , and a bi-partite 14-3-3 binding motif (Liu et al., 1997) .
Other Cbl family members, all containing the SH2 domain and RING ®nger, include Cbl-b (Keane et al., 1995) and Cbl-3 (Keane et al., 1999) . Cbl-3 is truncated relative to c-Cbl and Cbl-b, with a reduced proline rich region and entirely lacking the UBA domain. The two invertebrate orthologues, Drosophila D-Cbl (Hime et al., 1997; Meisner et al., 1997) and Caenorhabditis elegans Sli-1 (Yoon et al., 1995) , are also truncated with respect to c-Cbl: D-Cbl lacks all motifs C-terminal to the RING ®nger, while Sli-1, like Cbl-3, retains some proline rich motifs but lacks the UBA domain.
We describe here isolation of a new splice variant of D-cbl encoding a C-terminally extended protein closely resembling c-Cbl. A deletion of the D-cbl locus has been generated and used to demonstrate that an analogue of v-Cbl, Dv-Cbl, is a dominant-negative protein with oncogenic potential in Drosophila. Genetic interactions are demonstrated between D-cbl and components of the ubiquitin and endocytosis pathways using the dominant negative Dv-cbl allele. Finally, we show that c-Cbl co-immunoprecipitates with the Ese1 homologue Dap160, and that Dap160, D-Cbl, and dynamin are able to form a complex in vitro. This suggests that, in addition to possessing intrinsic ubiquitin ligase activity, Cbl proteins also function as direct adaptors between target proteins and the endocytic machinery. Thus, the transforming potential of Cbl mutants may re¯ect defects in endocytosis as well as ubiquitination. 
Results

D-cbl has an additional exon that encodes proline rich and UBA domains
A surprising feature of D-Cbl is that it lacks docking sites conserved between C. elegans and mammals. A Drosophila EST, HL01986, with strong similarity to the UBA domain of c-Cbl was identi®ed in the dbEST database. PCR ampli®cation of a fragment from an embryonic cDNA library that extended from exon 5 of D-cbl to the EST suggested that it was contiguous with D-cbl and represented a sixth exon (data not shown).
To con®rm this, two probes were used to screen duplicate ®lters of the embryonic library: one that hybridizes to exons 1-4 of D-cbl, and a second that hybridizes to the EST (see Figure 1b) . Four plaques hybridized to both the probes and two of these were found to contain a complete ORF corresponding to a new isoform of D-cbl. (Figure 2a,b) , con®rmed by hybridization to an exon 6 probe speci®c to D-cblL (Figure 2b ). The band is most clearly visible in mRNA extracted from wandering third instar larvae (Figure 2c ), the ®rst developmental stage at which D-cblL was detectable, and corresponding to the initiation of larval disc dierentiation. D-cblL was not detectable during embryonic development and was only weakly expressed during the larval third instar, pupal, and adult stages.
The exon 1 ± 4 probe recognized four additional bands, the largest of which, 2.5 kb in size, is encoded by the D-cblS ORF (Hime et al., 1997) . The developmental Northern shows that the 2.5 kb band is expressed at high levels at 0 ± 2 h of development, prior to the onset of embryonic gene expression, suggesting strong maternal expression. Levels tapered o during embryonic development and then reappeared in third instar larvae (Figure 2a , lanes 1 ± 8). As would be expected for a maternal transcript, levels of the 2.5 kb mRNA were much higher in adult females than males (Figure 2a , compare lanes 9 and 10) which was not observed for D-cblL. Thus, the dierent isoforms have dierent expression pro®les, suggesting that they may function independently of each other.
Deletions across the D-cbl locus have complex phenotypes
To generate D-cbl mutants for genetic analysis of the locus, a P-element located 1.5 kb 5' of the D-cbl locus, Pw+30, was mobilized and approximately 800 lines screened for deletion of or insertion into the D-cbl locus. Two lines were identi®ed in which the D-cbl locus was deleted, Df(3L)cbl1 and Df(3L)cbl2. Both have 5' breakpoints at the site of P-element insertion and as yet unde®ned 3' breakpoints at least 10 kb 3' of the D-cbl gene (Figure 3a ). Both de®ciencies are heterozygous wild type in appearance and embryonic homozygous lethal, and they fail to complement each other.
To characterize the phenotype of Df(3L)cbl1 homozygotes, the segmental patterning of the embryonic cuticle and peripheral nervous system were examined (see Materials and methods). The wild type segmental array of neurons ( Figure 3b ) was disrupted in Df(3L)cbl1 ( Figure 3c ) and some embryos failed to form the appropriate number of neurons in each segment. In the example shown, alternate segments failed to dierentiate resembling a pair-rule phenotype ( Figure 3c ). Phenotypes were pleiotropic, possibly due to varying degrees of maternal rescue, and this was . This de®ciency provides a tool for the isolation of speci®c D-cbl alleles, which will be necessary to determine whether all of the phenotypes observed are due to loss of D-cbl.
A v-Cbl analogue behaves as a dominant-negative protein in Drosophila
The availability of a deletion that removed the D-cbl locus allowed us to test if the v-cbl mutation acted in a genetically dominant-negative manner, which, although likely, has yet to be demonstrated. Therefore, the Gal4/ UAS system (Brand and Perrimon, 1993 ) was used to generate transgenic Drosophila carrying an analogue of v-cbl, Dv-cbl (truncated at conserved residue 306), under UAS regulation. Dominant negative proteins inhibit native protein function (Herskowitz, 1987) such that phenotypes associated with a dominant negative are enhanced by a reduction in the level or activity of the native protein. To test whether Dv-cbl is a dominant negative allele,¯ies with a recombined second chromosome carrying both UAS-Dv-cbl and GMRGal4
(GMR:Dv-cbl), were crossed to Df(3L)cbl1¯ies. GMRGal4 drives expression in all cells in the eye behind the morphogenetic furrow, and low levels of expression outside the eye (Hay et al., 1994) . Flies heterozygous for Df(3L)cbl1 were phenotypically wild type (Figure 4a,d ), while GMR:Dv-cbl eyes were slightly rough (Figure 4b ) with some ectopic R7-like photoreceptors (Figure 4e , arrow). In¯ies heterozygous for both Df(3L)cbl1 and GMR:Dv-cbl, the GMR:Dv-cbl phenotype was signi®-cantly enhanced, with pronounced disruption of the ommatidial array (Figure 4c) , and an increase in the number of ommatidia with ectopic photoreceptors (Figure 4 , compare e and f). This con®rmed that Dv-cbl is acting as a dominant negative protein.
Dv-Cbl is oncogenic
Expression of UAS-Dv-cbl driven by engrailed Gal4 (enGal4) caused hyperplasia of the humeral region in 5% of progeny (Figure 4g, arrowhead) suggesting that Dv-Cbl may have oncogenic capacity. To determine whether Dv-cbl can co-operate with other mutations to produce tumours, GMR:Dv-cbl¯ies were crossed tō ies with mutations in the Ras pathway. The combination of GMR:Dv-cbl and an activating mutation in Ras1 (sev-Ras1
V12
) at 258C or sevenless (sev S11 ) at 298C (at which expression of Gal4/UAS is increased) both produced melanotic tumours in the eyes in approximately 30 and 40% of progeny, respectively (Figure 4h,i) . Neither of these mutations causes tumours alone. Thus, Dv-cbl is able to cooperate with activating mutations in the Ras pathway to cause tumorous phenotypes in the Drosophila eye. This is particularly interesting as it also demonstrates that activated Ras1 can cooperate with other mutations to form melanotic tumours in Drosophila, something which has not previously been shown.
Dv-Cbl enhances signalling from Egfr
If D-Cbl is a negative regulator of receptor signalling, Dv-Cbl would be expected to increase signalling from receptors by interfering with endogenous D-Cbl function. To test this, GMR:Dv-cbl was crossed to¯ies carrying UAS-Egfr and UAS-Egfr×DN. In addition to a moderately rough eye (Figure 5a ) GMR:Dv-cbl expression causes some ectopic wing vein formation ( Figure  5f ), a biological read-out of Egfr signalling (DiazBenjumea and Garcia-Bellido, 1990 ). Similar eects were observed when UAS-Egfr expression was driven by GMRGal4 (Figure 5b,g ). The two together signi®cantly enhanced both the rough eye and extent of ectopic veins (Figure 5c and h), and the eect was clearly more than additive. GMR:Dv-cbl also substantially suppressed the eect of a dominant negative Egfr allele, truncated 13 amino acids C-terminal of the transmembrane domain. Expression of UAS-Egfr×DN driven by GMRGal4 led to complete loss of the adult retina (Figure 5d ), as previously reported (Freeman, 1996) . In animals raised at 298C, veins L2, L3, L4 and L5 were disrupted (Figure 5i ). Co-expression of UAS-Dv-cbl with UASEgfr×DN partially rescued both phenotypes. Retinal development was restored although the eye was smaller than wild type and ommatidial orientation was irregular ( Figure 5 , compare d and e). At 298C, veins L2, L3 and L5 were completely rescued, with partial rescue of L4 ( Figure 5 , compare i and j). This most likely re¯ects an interaction between Dv-Cbl and the endogenous Egfr, resulting in enhanced signalling through the wild type receptor, as Dv-Cbl should not be able to bind to the truncated Egfr×DN. These results show that at least one isoform of D-Cbl regulates Egfr signalling in a manner analogous to the negative regulation reported for Sli-1 .
A screen reveals interactions between D-cbl and other negative regulators of Egfr signalling
Another oncogenic D-cbl transgene, D-cbl-onc, was used to screen 40 Drosophila lines carrying deletions on the third chromosome. D-cbl-onc was generated by creating the 70Z deletion in D-cblS, which consists of the SH2 domain and RING ®nger. Thus D-cbl-onc encodes a protein analogous to Dv-Cbl as only the SH2 domain remains intact (see Figure 1a) . Furthermore, UAS-D-cbl-onc and UAS-Dv-cbl are phenotypically alike when expressed under the regulation of any of 20 dierent Gal4 lines and both GMR:D-cbl-onc and GMR:Dv-cbl genetically interact with the same mutations in the same way (data not shown).
The screen speci®cally identi®ed three loci that enhance the GMR:D-cbl-onc phenotype spanning the argos and Gap1 loci, and a region containing several uncharacterized loci. Point mutations in argos and Gap1 were able to enhance the phenotype of both GMR:D-cbl-onc and GMR:Dv-cbl (for example, see Figure 5k ), con®rming the results of the screen. Argos and Gap1 are both negative regulators of Egfr signalling in Drosophila (Feldmann et al., 1999; Schweitzer et al., 1995) . Thus the speci®c interaction of argos and Gap1 with D-cbl-onc provides further evidence of a role for D-Cbl as a negative regulator of Egfr signalling. As the deletions used were all cytologically visible, therefore spanning a minimum of 50 kb each, this demonstrates that genetic interactions of oncogenic D-cbl mutations are highly speci®c, as well as showing that the Dv-cbl and D-cbl-onc alleles will be suitable for use in more extensive genetic screens.
Dv-cbl interacts with mutations in the endocytic pathway c-Cbl null macrophages show defective endocytosis of the CSF-1R (Lee et al., 1999) . Furthermore, a yeast two hybrid screen (Robertson et al., 1997) uncovered interactions between c-Cbl and two proteins involved in receptor endocytosis: unconventional myosin 1C (Bement et al., 1994) , required for endocytosis of the afactor receptor in yeast (Geli and Riezman, 1996) ; and Ese1, a homologue of Drosophila Dap160, which interacts with dynamin through one of its four SH3 domains (Roos and Kelly, 1998) and functions in receptor endocytosis in both yeast and mammals (Sengar et al., 1999; Wendland and Emr, 1998) . The interaction between Dv-cbl and Dap160, was tested genetically using EP element insertions in the Dap160 locus. EP element transposons contain a UAS element and generally lead to over-expression of adjacent genes in the presence of Gal4 (Rorth et al., 1998) . Overexpression of Ese1 has a dominant negative eect (Sengar et al., 1999) , as has been observed for several other adaptor proteins (for example Wigge et al., 1997) . Since Dv-cbl is also a dominant negative, Dap160 EP alleles would be expected to enhance the Dv-cbl phenotype. GMR:Dv-cbl¯ies have a small amount of ectopic vein on the wings (Figures 5f and  6a) . In a wild type background, over-expression of Dap160 from either of two EP insertions driven by GMRGal4 produced a phenotypically wild type wing (e.g. Figure 6b ). Co-expression of Dv-cbl resulted in an increase in ectopic veins (e.g. Figure 6c ) compared to GMR:Dv-cbl alone (Figure 6a ). This analysis was extended to include mutations in genes whose products function at known points in the endocytic pathway: shibire (the Drosophila dynamin homologue), a-adaptin, and several proteins involved in ubiquitination. Studies with shibire and mammalian dynamin show that it is required for clathrin mediated endocytosis (reviewed in McNiven, 1998); a-adaptin is an essential component of the AP-2 complex associated with clathrin coated pits (Hirst and Robinson, 1998) ; and it is known that ubiquitination and endocytosis of many receptors are interdependent events (Govers et al., 1997; Roth et al., 1998; Strous et al., 1996) .
The extent of ectopic vein formation in GMR:Dv-cbl ies ranges from virtually wild type to a small amount of ectopic vein on one or both wings (compare Figures 5f  and 6a) . No interaction was detected with either of the two alleles of a-adaptin, however the phenotype of GMR:Dv-cbl was qualitatively enhanced by a single copy of the hypomorphic shibire allele shi ; GMR:Dv-cbl wings had the ectopic vein phenotype shown in Figure 6d as compared to 0% of GMR:Dv-cbl alone (Figure 6a) . A similar enhancement was seen with shi ×ts2 and shi ×ts3 (data not shown). The phenotype of all shibire alleles alone, or in combination with GMRGal4, was indistinguishable from that shown in Figure 6b (data not shown).
Ubiquitination involves a complex of ubiquitin activating enzyme (E1), a ubiquitin conjugating enzyme (E2), and a ubiquitin-protein ligase (E3), as well as the target protein, (reviewed in Bonifacino and Weissman, 1998) . GMR:Dv-cbl¯ies were crossed to strains carrying mutations in the E2, UbcD1 (e); the sumospeci®c E2 Ubc 9, (semi/lwr), and the E3, UBE 3A (hyd). As a control, all mutations were crossed to GMRGal4 alone and no interaction was detected (data not shown). The extent of ectopic wing vein and roughening of the eye seen in GMR:Dv-cbl¯ies was enhanced by both a null and a reduction-of-function allele of UbcD1 (Figure 6e and data not shown). A reduction-of-function allele of UBE 3A also enhanced the wing vein phenotype, though to a lesser extent, but not the eye phenotype (Figure 6f) . No enhancement was observed with Ubc 9 (Figure 6g ). These results are consistent with the E3 function of Cbl proteins, as well as with a role for D-Cbl in endocytosis.
D-Cbl forms a complex with dynamin and Dap160
To test for a direct interaction between D-CblL and endocytic proteins, S-methionine labelled D-CblL were subjected to an in vitro binding assay. GST-Drk (the Drosophila Grb2 homologue) was used as a positive control as Grb2 is known to interact with c-Cbl and dynamin (Gout et al., 1993) . GST alone was used as a negative control. Proteins were combined and precipitated using glutathione agarose beads. A small amount of dynamin, but not D-CblL, was precipitated by GST alone (Figure 7a, lanes 1 and 2) . GST-Dap160 was able to bind to both dynamin and D-CblL (lanes 3 and 4) . The interaction of GST-Dap160 with D-cblL was weaker than with dynamin. GST-Drk was also able to bind both D-CblL and dynamin, and the same relative strengths of interaction were observed (lanes 5 and 6). This demonstrates that D-cblL is able to bind Drk, as well as demonstrating a direct interaction between DcblL and Dap160, and suggests that at least one of the proline rich motifs encoded by the new exon forms a functional SH3-binding domain.
To examine the interaction between D-CblL and Dap160 in vivo, immunoprecipitates prepared with an antibody directed against D-Cbl were immunoblotted for the presence of Dap160. A doublet was detected that was identical in electrophoretic mobility to a doublet immunoprecipitated by antibodies directed against Dap160 (Figure 7b , compare lanes 1 and 2 to 3 and 4), con®rming an in vivo interaction between these proteins.
Dap160 contains four SH3 domains, and interacts with dynamin through one or more of them. If D-CblL links receptors to the endocytic pathway through its interaction with Dap160, it would be expected to interact with Dap160 that is bound to dynamin. To determine if this is possible, 35 S-labelled in vitro translated D-CblL and dynamin, with or without GST or GST-Dap160, were immunoprecipitated with an antibody directed against D-Cbl. As before, a small amount of dynamin was non-speci®cally precipitated in the absence of Dap160 (Figure 7c, lanes 1 and 3) , but several fold more was precipitated in the presence of Dap160 (Figure 7c, lane 2) . This was highly reproducible in repeated experiments and demonstrates that Dap160 can mediate an interaction between D-CblL and dynamin, thus forming a complex which could act to facilitate endocytosis of activated receptors.
This interaction, in combination with the Dap160 interaction, strongly suggests a role for D-CblL in endocytosis.
Discussion
The new isoform of D-Cbl is an orthologue of c-Cbl and Cbl-b
Genetic screens and analyses in Drosophila have made signi®cant contributions to the understanding of signal transduction and continue to identify novel components of these pathways that were not exposed by biochemical means. As it is becoming clear that factors involved in signal down-regulation also play a role in signal speci®cation, application of these genetic approaches to uncovering components of negative regulatory complexes will also be of substantial interest. The identi®cation of a new D-cbl exon encoding several proline-rich motifs, as well as potential sites of tyrosine phosphorylation, reveals that there are two D-cbl splice forms encoded by a single locus. Sequence homology suggests that D-CblL is a direct orthologue of c-Cbl and Cbl-b and is suciently related to mammalian Cbl proteins to be suitable for genetic analysis of the functions of these proteins. Furthermore, the existence of a de®ciency and a dominant negative allele of D-cbl will allow the identi®cation of speci®c D-cbl alleles, as well as the execution of genetic screens, the feasibility of which has been demonstrated here.
The relationship of D-CblS to other Cbl proteins is not clear. Cbl-3 and Sli-1 are also truncated with respect to c-Cbl and Cbl-b, and lack the UBA domain, but they are not exactly analogous to D-CblS as they retain a short proline-rich region. This suggests that there may be a fourth mammalian Cbl. The possible functional relationship between the D-Cbl isoforms is discussed below.
Dv-cbl is a dominant negative oncogene
The enhancement of the Dv-cbl phenotype by a single copy of a D-cbl de®ciency is the ®rst formal evidence that the v-cbl truncation creates a dominant negative mutation. This is supported by the observation that both GMR:Dv-cbl and Df(3L)cbl1 enhance the phenotype of Ellipse, an activating mutation in Egfr (Robertson, Hime and Bowtell, unpublished) , demonstrating that they behave similarly with respect to the Egfr. It should be pointed out that the de®ciency used in these experiments, generated by P-element excision, may encompass other loci in addition to D-cbl. It is unlikely, however, that there is a second locus within a few kilobases that behaves as predicted for a D-cbl de®ciency with respect to both Dv-cbl and the Egfr.
The strong suppression of the Egfr×DN phenotype when Dv-cbl is co-expressed (Figure 5d ,e) as well as the enhancement observed when Egfr and Dv-cbl are coexpressed (Figure 5a ,b,c), con®rm that Dv-Cbl is able to enhance signalling from Egfr, as would be expected for a dominant negative mutation in a negative regulator. In addition, this is the ®rst in vivo evidence that v-Cbl enhances signalling through the Egfr.
The formation of ectopic veins in response to Dv-cbl expression may re¯ect a role for D-cbl in imaginal disc cellular dierentiation. In addition, Dv-cbl partially rescued defects in the size and shape of wings expressing Egfr×DN (Figure 5i ,j) which may re¯ect a role for D-cbl in cellular proliferation. This is also evident in the formation of tumours in the eye in the presence of activating mutations in Ras1 and sevenless, and in the hyperplasia observed in the humeral region of¯ies expressing Dv-cbl under enGal4 regulation (Figure 4g,h,i ).
D-CblL may have a dual role in receptor down-regulation
We have shown both genetic and biochemical interactions between D-Cbl and dynamin, a protein essential for endocytosis, and the ability of a D-Cbl/Dap160/ dynamin complex to form in vitro. The heterozygous modi®er interactions of Dv-cbl with UbcD1 and hyd are also consistent with the established role for c-Cbl in ubiquitination of the CSF-1R, EGFR, and PDGFR. The interaction between Dv-cbl and hyd may re¯ect an ability of hyd, which is also an E3, to compensate partially for the reduction in D-Cbl activity produced by the expression of Dv-Cbl. Ubc9 is functionally distinct from UbcD1 and hyd as it conjugates sumo rather than ubiquitin. The fact that no interaction was observed between Dv-cbl and Ubc9 demonstrates the speci®city of this assay. These interactions, coupled with the ability of D-Cbl, Dap160, and dynamin to form a complex, are interesting as the ubiquitin system is required for the endocytosis, and endocytosis is required for the ubiquitination, of many receptors (Govers et al., 1997; Roth et al., 1998; Strous et al., 1996) . Thus, Cbl proteins may provide a scaold for the formation of a combined ubiquitination-internalization complex and may represent a class of molecules that ensures ecient endocytosis and processing of activated receptors. The transforming eect of Dv-Cbl could be explained by the failure of receptor downregulation through a block to D-Cbl-mediated ubiquitination and endocytosis. It is well documented that failure of the EGFR to undergo internalization is transforming (for example Masui et al., 1991; Wells et al., 1990) , so if the complex regulates receptor endocytosis, this could account for the oncogenicity of the CblDY368 mutant that retains E3 activity. The utilization of a single protein for both endocytosis and ubiquitination could explain the interdependence between these events in down-regulation of the growth hormone receptor (Govers et al., 1997) , and suggests that this linkage may be common to many receptors. Alternatively, there may be two dierent mechanisms underlying Cbl-mediated transformation. The ®rst would be a defect in ubiquitin ligase activity in the case of v-Cbl and 70Z/3-Cbl. CblDY368, and any other transforming mutants that are shown to be wild type for ubiquitin ligase activity, would therefore be transforming via an alternate mechanism such as defects in transport or an as yet unknown function of Cbl proteins, or through a gain-of-function.
As the endocytic system is easily saturated by overexpression of the EGFR (for example Carter and Sorkin, 1998; Wiley, 1988) con®rmation of the role of Cbl proteins in receptor internalization may depend on the development of assays that can measure physiological levels of receptor endocytosis.
What is the functional relationship between D-CblL and D-CblS?
There are now known to be at least three mammalian Cbl family proteins, c-Cbl, Cbl-b, and Cbl-3. It will be of central importance to determine the functional distinctions among these proteins, and examination of the relationship between D-CblL and D-CblS will therefore be of particular interest. It is possible that DCblL functions in ligand-induced ubiquitination/internalization and targeted degradation of cell-membrane associated proteins, while D-CblS may function in other aspects of ubiquitination and degradation. Interestingly, Dv-cbl produced no phenotypic eect when expressed in embryos (Robertson, Hime and Bowtell, unpublished results) . The only detectable DCbl isoform in embryos is D-CblS, suggesting that DvCbl may be speci®cally aecting function of D-CblL. Further genetic analysis will allow us to determine whether Dv-Cbl is dominant negative with respect to one or both of the endogenous isoforms and what cellular processes are being disrupted leading to tumour formation.
Materials and methods
Library screens, Southern analysis, Northern analysis, and DNA constructs Library screens and Southerns were performed according to standard protocols (Sambrook et al., 1989 ) using probes directed against exons 1 ± 4 of D-cbl and the D-cblL speci®c exon 6. The embryonic LD cDNA library was from G Rubin (UC Berkeley, USA). The genomic library was from Clontech. Northerns were performed according to standard protocols (Sambrook et al., 1989) using 3 mg polyA + RNA and a probe directed against exons 1 ± 4, or 6.
The UAS-Dv-Cbl construct was generated by restriction digest and ligation of a 1.5 kb fragment encoding D-Cbl amino acids 1 ± 345 into pUAST (Brand and Perrimon, 1993) . UAS-D-cbl-onc was generated by site directed mutagenesis to introduce the 70Z deletion (amino acids 354 ± 70) into D-cblS, followed by restriction digest and ligation of a fragment into pUAST. The GST-Dap160 construct was from Jack Roos (UC San Francisco, USA). The dynamin (shibire) construct was from L Kelly (Melbourne University, Australia).
Drosophila stocks and germline transformation
Stocks were maintained at 258C on standard medium supplemented with live yeast. Crosses were performed at 258C or 298C. Stocks used were GMRGal4, UAS-Egfr, and , and EP (2)2543 Dap160 from the Bloomington Stock Centre.
Df(3L)cbl1 and 2 were generated by imprecise excision of a P-element insertion 5' to the D-cbl locus. GMR:Dv-cbl was generated by recombining a UAS-Dv-cbl second chromosome insertion onto a GMRGal4 bearing second chromosome.
Germline transformants were generated by P-element mediated transformation according to standard protocols Spradling and Rubin, 1982) with w 1118 as the host strain.
Histochemical and microscopic analysis
Embryonic cuticle preparations were performed as described in Wieschaus and Nusslein-Volhard (1986) . Immuno¯uorescence was performed as previously described (Hime et al., 1997) . For scanning electron microscopy adult¯ies were dehydrated in an ethanol series and critical point dried. Mounted samples were gold coated and observed on a Phillips SEM 515. Wings were dissected and mounted in 50% ethanol, 50% lactic acid. Sections of adult eyes were prepared as described in (Tomlinson, 1985) .
Immunoprecipitation of Drosophila proteins
In vitro binding assays using 35 S-labelled in vitro translated proteins (Promega) were performed as described previously (Rozakis-Adcock et al., 1993) . Immunoprecipitations and Western blots were performed according to Lai et al. (1995) . The Dap160 and dynamin antibodies were from Jack Roos (UC San Francisco, USA).
